You are here

QT Vascular sells IP rights for its coronary products to US firm


MEDTECH firm QT Vascular on Thursday said it has entered into an asset purchase-and-option agreement with Teleflex Life Sciences Unlimited Company and New York-listed Teleflex Incorporated to sell the firm's intellectual property rights to its non-drug coated coronary products,

Market voices on: